Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.45
-0.85 (-6.39%)
Sep 8, 2026, 1:53 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.75 billion as of September 8, 2026. Its market cap has decreased by -26.33% in one year.
Market Cap
7.75B
Enterprise Value
4.55B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.45
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.75B, a decrease of -66.18%. That is a compound annual growth rate of -29.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 7.75B | -13.25% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 8.90B |
| Tanvex BioPharma | 8.40B |
| PharmaEngine | 8.30B |
| Locus Cell | 8.09B |
| TWi Biotechnology | 7.79B |
| Adimmune | 7.40B |
| Savior Lifetec | 6.35B |
| TaiGen Biopharmaceuticals Holdings | 6.23B |